GuoLine Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.3M | Buy |
67,300
+11,000
| +20% | +$5.78M | 3.75% | 11 |
|
|
2025
Q1 | $35.7M | Buy |
56,300
+9,940
| +21% | +$6.3M | 3.78% | 12 |
|
|
2024
Q4 | $33M | Buy |
46,360
+14,300
| +45% | +$10.2M | 3.41% | 13 |
|
|
2024
Q3 | $33.7M | Hold |
32,060
| – | – | 3.43% | 16 |
|
|
2024
Q2 | $33.7M | Buy |
32,060
+6,160
| +24% | +$6.47M | 3.6% | 16 |
|
|
2024
Q1 | $24.9M | Buy |
+25,900
| New | +$24.9M | 3.04% | 18 |
|